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p21Waf1/Cip1 REGULATES PROLIFERATION AND APOPTOSIS IN
AIRWAY EPITHELIAL CELLS AND ALTERNATIVE FORMS HAVE
ALTERED BINDING ACTIVITIES
Renald Blundell, David J. Harrison, and Shirley O’Dea Pathology
Department, University of Edinburgh, Scotland
p21Waf1/Cip1 plays central roles in proliferation, differentiation, and apoptosis. Alterations in
the expression and subcellular localisation of p21 occur during several lung diseases but the roles
of p21 in the lung epithelium are unknown. The effects of p21 on proliferation and apoptosis in
mouse airway epithelial cells (AECs) were examined using p21-null mice. AECs isolated from
p21-null mice had increased proliferation and apoptotic rates compared to AECs from wild-type
mice. Alterations in the subcellular localization of the cell cycle regulatory proteins p27, PCNA,
and p53 were also evident in p217/7 cells. The nuclear and cytoplasmic forms of p21 present
in AECs were also examined. Full-length p21 (20 kDa) was detected in nuclear fractions but a
C-terminal truncated form (17 kDa) of p21 was present in cytoplasmic fractions. The binding ac-
tivities of truncated p21 were altered compared to full-length p21. Although the latter was complexed
with PCNA, Cdk2, Cdk4, Cdk6, cyclin D3, and cyclin E, truncated p21 was bound only to Cdk4
and cyclin D3. In conclusion, p21 regulates proliferation and protects against apoptosis in AECs.
In addition, different forms of p21 are present in AECs and the subcellular localization of these
forms reflects differences in p21 activity.
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p21Waf1/Cip1 (referred to hereafter as p21) is a member of the Cip/Kip family
of cyclin-dependent kinase inhibitors (CKIs) that also includes p27Kip1 and
p57Kip2. These proteins interact directly with the cyclin/cyclin-dependent
kinase (CDK) complexes that drive both the G1/S and G2/M phases of
the cell cycle [1]. Initially thought to be inhibitors of cyclin/CDK com-
plexes, it has more recently been proposed that low levels of p21 and p27
in fact facilitate cyclin D/CDK interactions in the cytoplasm and their sub-
sequent translocation to the nucleus [2, 3]. Once in the nucleus, cyclin
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D/CDK complexes sequester low levels of p21 and p27, allowing cyclin E/
CDK complexes to remain active and permitting cell cycle progression. Only
when p21 and p27 levels are sufficiently high will they interact with and inhi-
bit cyclin E/CDK complexes also. In contrast, however, it has also been
reported that cyclin D3/CDK4 complexes containing p21 or p27 are inactive
both in vivo and in vitro and that neither p21 nor p27 are required for for-
mation of cyclin D3/CDK4 complexes [4]. Thus, the precise roles of Cip/
Kip proteins in cell cycle regulation remain unclear. Furthermore, the
extent to which the functions of these proteins overlap and can compensate
for each other is also unknown.
In addition to their interactions with cyclin/CDK complexes, Cip/Kip
proteins interact with a wide range of other proteins both in the cytoplasm
and in the nucleus. In the cytoplasm, p21 interacts with stress-activated
protein (SAP), ASK kinases, and caspase 3 to modulate apoptosis [2].
p21 is generally considered to inhibit apoptosis [5], particularly when
localized to the cytoplasm [6]. However, several reports also describe
induction of apoptosis by p21, usually in the absence of functional p53
(reviewed in reference 7). Interactions between p21 and calmodulin may
also be important in translocation of p21 complexes to the nucleus [8].
In the nucleus, p21 interacts directly with a number of cell cycle
regulatory proteins and transcription factors including PCNA, GADD45,
STAT3, c-Myc, CK2, and C/EBP-a [2]. There are fewer reports of direct
interactions of p27 and p57 with proteins other than cyclin/CDK
complexes. p27 is known to bind to the nuclear pore–associated protein
mNPAP60 [9] and the exportin Jab1/CSN5 [10]. p57 binds to and
stabilizes the muscle-specific transcription factor MyoD, suggesting an
important role for p57 in lineage-specific differentiation [11]. More
recently, p57 has also been found to interact directly with p53 [12]. The
effects of this interaction on the functions of either protein are as yet
unclear. The p21 gene appears to be more readily inducible than p27 or
p57 by a wide rage of molecules, including vitamin D3, retinoic acid,
interferon (IFN)-g, epithelial growth factor (EGF), and interleukin (IL)-6
(reviewed in reference 13). p21 may therefore be the principal Cip/Kip
protein responsible for regulation of responses of adult cells to local
environmental cues and may exert a protective function against stress [14].
In the lung epithelium, expression of the individual Cip/Kip proteins
varies with maturation stage and also in a number of disease states. p57
levels are highest during lung development, particularly in the airways
[15], and subsequently decline postnatally during maturation and aging
[16, 17]. p27 is expressed in quiescent adult airway and alveolar epithelial
cells and its expression may be linked to differentiation stage [18]. p21
expression is widespread in developing lungs [15], but levels decline in
normal adult lung cells [18]. Somewhat surprisingly, mutations in Cip/Kip
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genes are rare in human tumours and only p27 has been strongly linked
with lung cancer. Decreased p27 protein levels are associated with non–
small cell lung cancer and poor patient outcome [19], whereas conversely,
increased levels occur frequently in small cell lung cancer [20].
Interestingly, alterations in expression levels and subcellular localization of
p21 have been noted in epithelial cells during several lung diseases.
Elevated protein levels and nuclear localization of p21 have been
demonstrated in airway epithelial cells of patients with severe asthma
[21]. Cytoplasmic localization of p21 may correlate with suppression of
cell proliferation in bronchial squamous cell carcinoma, whereas nuclear
localization appears to coincide with high cell proliferation [22].
Increased p21 expression has also been reported in lung epithelial cells
during idiopathic pulmonary fibrosis [23] and immune complex alveolitis
[24]. However, despite being key regulators of the cell cycle, the roles of
Cip/Kip proteins in normal and abnormal processes within the lung
epithelium have not been investigated.
We have utilized p21-null mice to explore the roles of p21 in airway
epithelial cells. p27-null mice display increased body size [25] and p57-
null mice display severe developmental defects, increased apoptosis, and
delayed differentiation [26], although no specific lung effects have been
observed in either knockout animal. In contrast, p21 knockout mice
appear to develop and grow normally up to about 16 months when they
develop spontaneous malignancies [27, 28]. As with p27- and p57-null
animals, no effects of p21 loss on lung cell function have been reported
in vivo or in vitro. However, mice lacking both p21 and p57 show altered
lung development with failure to form normal air sacs, although the
defective cell types have not been identified, indicating that these proteins
may compensate for each other in the single knockout animals [15].
Interestingly, the bronchial tree is unaffected in the double knockout
animals. p21 chimeric mice also appear normal [29]. In contrast to most
of the in vivo studies, the effects of p21 loss are more readily apparent in
in vitro studies. Cultured murine embryonic fibroblasts from p217/7 mice
have been found to be impaired in their ability to arrest in G1 in
response to DNA damage and at later passages achieve higher saturation
densities than wild type control cells [27]. We have found that cultured
p217/7 mouse airway epithelial cells (AECs) have increased proliferation
and apoptotic rates compared to wild-type AECs, demonstrating that p21
plays a central role in these processes in lung epithelial cells and that
these activities cannot be compensated for by other Cip/Kip proteins. We
have also examined the significance of the subcellular localization of p21
in AECs and identified a novel truncated form of mouse p21 in
cytoplasmic fractions. This truncated p21 protein has modified binding
activity compared to full-length mouse p21.
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MATERIALS AND METHODS
Animals and Cell Culture
p21-null mice were kindly provided by Philip Leder, Harvard Medical
School, Boston, USA. C57 black 6 mice were used as control animals.
AECs were isolated as described previously [30], seeded onto multiwell slides
precoated with 50 ng/mL fibronectin and cultured in Dulbecco modified
Eagle medium (DMEM):Hams F12 medium (1:1) supplemented with 5%
fetal calf serum and 2mML-glutamine at 37C, 5% CO2. Because AECs
are isolated and seeded in clumps, counting of cells is not feasible. In order
to consistently seed wells at equal densities, an aliquot of cells was taken
prior to seeding and absorbance reading was obtained using the reagent
from the CellTiter Assay used in the MTS ((3-(4-5-dimethylthinzol-2-yl)-
5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt)
proliferation assay described below. Cell suspensions were diluted and
seeded accordingly.
Histology
Formalin-fixed, paraffin-embedded tissue sections were dewaxed in
xylene, rehydrated, and stained with hematoxylin and eosin.
Immunofluorescence
Formalin-fixed, paraffin-embedded tissue sections were dewaxed and
rehydrated. Cultured cells were fixed in prechilled methanol for 5minutes
at 7 20C. Primary antibodies were incubated for 2 hours at room tempera-
ture. Antibodies used were as follows: p21 (DAKO, clone SX118), p27
(Sigma, clone DCS-72), p57 (Santa Cruz, clone M30), PCNA (Sigma, clone
PC10), and p53 (Vector Laboratories, clone CM5p). Tissue sections were
then incubated with biotinylated secondary antibodies (DAKO) followed
by StreptABcomplex (DAKO) and stained with Vector Red substrate (Vector
Laboratories). Cultured cells were incubated with appropriate Alexa Fluor
fluorescent secondary antibodies (Molecular Probes) and counterstained
with DAPI nuclear stain.
MTS Proliferation Assay
CellTiter 96 Aqueous One Solution Cell Proliferation Assay (Promega)
colorimetric assay was used according to manufacturer’s instructions to
determine cell proliferation rates. Briefly, 20 mL reagent was added to each
test well containing 100 mL fresh culture medium. Cells were incubated for 1
hour at 37C and supernatant absorbance at 490 nm was determined.
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BrdU Incorporation Assay
At days 1, 3, or 5 of culture, cells were incubated with 10mM BrdU for 6
hours, rinsed with phosphate-buffered saline (PBS), and fixed with 70%
ethanol at 4C for 1 hour. Cells were then rinsed with PBS and incubated
with 5 M HCl for 45 minutes followed by 1% hydrogen peroxide for 10 min-
utes. Cells were then incubated with rat anti-BrdU-HRP (horseradish perox-
idase) primary antibody (Oxford Biotech) and binding was visualized using
Diaminobenzidine (DAB) solution. An average of 1000 cells were counted
using a HOME microscope.
Feulgen Stain for Apoptosis
Cells were fixed in Bouins fixative (17:1:2 methanol:glacial acetic
acid:40% formalin) for 12 hours at 4C, incubated in 5 M HCl for 45 min-
utes, rinsed with H2O, and incubated in Schiff’s reagent for 1 hour. Stain
was developed by rinsing with H2O and cells were then counterstained with
Light Green. Apoptotic nuclei were counted using a HOME microscope.
Protein Extracts
Cells were lysed in RIPA buffer for total protein extracts. Lysates were
centrifuged at 15,000 rpm for 10 minutes at 4C and supernatants were
collected. For cytoplasmic extracts, 1 106 cells were lysed in 100mL cyto-
plasmic lysis buffer (50 mM sodium fluoride, 5 mM tetra sodium pyropho-
sphate, 1 mM sodium orthovanadate, 10 mM b-glyceropyrophosphate,
0.5% NP-40, 2 mM EDTA, 20 mM disodium hydrogen phosphate, 20 mM
monosodium dihydrogen phosphate, and protease inhibitor (1 cocktail
tablet [Roche] per 10 mL). Lysates were centrifuged at 6500 rpm, 4C for
10 minutes and the supernatants (cytoplasmic extracts) were collected.
100 ml nuclear lysis buffer (as for cytoplasmic buffer plus 0.3 M sodium chlor-
ide) was added to the remaining cell pellets, which were then incubated on
ice for 10 minutes. The resulting lysate was centrifuged at 15,000 rpm, 4C
for 10 minutes, and the supernatant (nuclear extract) was collected.
Immunoprecipitation
Lysates were immunoprecipitated using an ‘IMMUNOcatcher’ kit (Cyto-
Signal) according to the manufacturer’s instructions. Primary antibodies
specific for PCNA (clone PC10, Sigma), Cdk2 (polyclonal, Sigma), Cdk4
(clone DCS-31, Sigma), Cdk6 (clone DCS-90, Sigma), cyclin D3 (clone
DCS-22, Sigma), and cyclin E (polyclonal, Sigma) were incubated with cell
lysates and complexes were precipitated using protein A/G resin.
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Western Blotting
Proteins were separated by sodium dodecyl sulfate (SDS)-polyacrylamide
gel electrophoresis and transferred onto nitrocellulose membrane. Blots
were incubated with primary antibodies directed against either the C-term-
inal end of human p21 but which also recognizes mouse p21 (C-19, Santa
Cruz) or full-length mouse p21 (F-5, Santa Cruz) followed by HRP-labeled
secondary antibody. Chemiluminescence detection was then carried out.
RESULTS
Histological Analysis of p217/7 Lungs
The gross morphology of p217/7 lungs was similar to that of wild-type
lungs. However, a slight flattening of the epithelial cells lining both large
and small airways of p217/7 mice compared to those of wild-type airways
was apparent (Figure 1). This indicates that p21 may play a role in the
differentiation of airway epithelial cells.
Expression of Cip/Kip Proteins in Airways of p217/7
and Wild-Type Mice
To determine whether compensatory up-regulation of p27 and p57
occurs in p217/7 airways in the absence of p21, lung sections were immu-
nostained for Cip/Kip proteins (Figure 2). p21 was confirmed absent in
FIGURE 1 Histology of wild-type (A) large and (B) small airways and p217/7 (C) large and (D) small
airways. H&E staining shows airway epithelial cells are slightly flattened in p217/7 lungs compared with
wild-type.
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p217/7 lung tissue whereas in wild-type lungs, p21 was localized mainly
to the cytoplasm of airway cells, with very occasional nuclear localization
evident. Strong cytoplasmic immunostaining for p27 was observed in wild-
type airways with a similar pattern occurring in p217/7 lungs. Immuno-
staining for p57 was weaker than that for p27 but again, a similar cytoplasmic
staining pattern was present in both wild-type and p217/7 lungs, suggesting
that compensatory up-regulation of p27 and p57 protein expression does
not occur in p217/7 airway cells. However, it remains possible that the
FIGURE 2 Immunostaining of wild-type and p217/7 airways for Cip/Kip proteins. (A) Positive cyto-
plasmic and nuclear (arrow) immunostaining for p21 in wild-type airways. (B) Negative immunostaining
for p21 in p217/7 airways. p27 immunostaining in (C) wild-type and p217/7 (D) airways. p57 immu-
nostaining in (E) wild-type and (F) p217/7 airways. (G) Isotype control for p21 and p27. (H) Isotype
control for p57.
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activities of p27 and p57 are altered in p217/7 animals at a level other than
up-regulation of protein expression or alternatively that proteins other than
the Cip/Kip family can compensate for loss of p21 activity.
Comparison of Proliferation Rates in Wild-Type and p217/7
Cultured AECs
Findings from previous studies suggest that under normal conditions,
p217/7 animals retain a normal phenotype. The effects of p21 loss only
become apparent when p217/7 cells are subjected to stress such as in vitro
culture or DNA damage [27], or older ages in the case of p217/7 animals
[28]. In these circumstances, information about the specific activities of p21
can be obtained. Therefore, in order to more closely examine the role of
p21 in airways, AECs were isolated and cultured. Proliferation assays were
carried out to compare proliferation rates between wild-type and p217/7
cells in vitro. In the MTS assay, a tetrazolium compound is metabolically
reduced by dehydrogenase enzymes in metabolically active cells. AECs iso-
lated from wild-type mice increased approximately 5-fold over the 5 days
of culture. In contrast, cells isolated from p217/7 cells increased approxi-
mately 17-fold during the same culture period (Figure 3A). An alternative
FIGURE 3 p217/7 proliferation assays. (A) MTS proliferation assay was used to determine the fold
increase in cells over 5 days of culture. (B) BrdU incorporation assay. Percentage BrdU positive nuclei
were counted over 5 days of culture.
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proliferation assay, BrdU incorporation, was also carried out to ensure that
potential metabolic differences between wild-type and p217/7 cells did not
account for the differences seen in the MTS assay. Similar results were
obtained with the BrdU assay. Approximately 5% to 10% wild-type cells were
in S-phase of the cell cycle at each time point, as determined by BrdU-
positive nuclei, wereas 20% to 30% p217/7 cells were in S phase at equiva-
lent time points during culture (Figure 3B). These results indicate that p21
plays a key regulatory role in the cell cycle of AECs and demonstrates that
p27 and p57 cannot replace these specific functions.
Apoptosis in Cultured AECs
p21 plays a central role in regulation of apoptosis, although its effects
appear to vary with cell type. It was found that apoptosis rates in p217/7
AEC cultures were approximately twice those of wild-type AEC cultures
(Figure 4). Therefore, p21 appears to play a role in the protection of airway
epithelial cells against apoptosis and this function cannot be replicated by
p27 or p57 in these cells.
Subcellular Localization of p27, PCNA, and p53 in p217/7 AECs
Further investigations into the regulatory role of p21 in cell cycle pro-
gression and apoptosis were carried out by comparing the subcellular loca-
lization of key proteins involved in these processes in wild-type and p217/7
cells. The incidence of both cytoplasmic and nuclear p27 was increased in
the absence of p21 during culture (Figure 5A). In the case of PCNA, cyto-
plasmic and nuclear levels were similar in wild-type and p217/7 cells at days
1 and 3 of culture but remained elevated at culture day 5 in p217/7 cells,
whereas they became reduced in wild-type cells (Figure 5B). Similarly, both
cytoplasmic and nuclear p53 remained elevated in p217/7 cells at day 5 of
culture compared to wild-type cells (Figure 5C). p21 therefore influences
the subcellular localization of p27, PCNA, and p53 and this presumably
FIGURE 4 Apoptosis in p217/7 cells. Feulgen staining was used to determine the percentage of
apoptotic cells present in cultured cells.
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reflects altered activity of these proteins. Alterations in the activities of PCNA
and p53 in the absence of p21 and the sustained levels of expression of these
proteins in p217/7 cells at day 5 of culture are likely to be responsible, at
least in part, for the increased rates of proliferation and apoptosis observed
in p217/7 AECs.
Subcellular Localization of p21 in AECs
The above studies demonstrate that p21 plays key roles in airway cell
proliferation and apoptosis and that these activities are not fully compen-
sated for by other Cip/Kip family members in cultured AECs. In order to
FIGURE 5 Subcellular localization of (A) p27, (B) PCNA, and (C) p53 in wild-type and p217/7 cells
over 5 days of culture.
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FIGURE 6 Subcellular localization of p21 during culture. Nuclear and cytoplasmic localization of p21 in
cultured primary AECs at (A) day 1, (C) day 3, and (E) day 5. (G) Isotype control. Panels (B, D, F, H) show
respective DAPI counterstains.  63 magnification. (I) Percentage of cells with cytoplasmic or nuclear
localization of p21.
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more closely examine the roles of p21 in these processes, the fluctuations in
the subcellular localization of p21 in wild-type AECs were examined over
time in culture (Figure 6). At culture day 1, p21 was localized predominantly
to the cytoplasm, with approximately 5% cells displaying nuclear localiza-
tion. There was an increase in nuclear p21 to 20% on day 3, with a slight
reduction in cytoplasmic p21. On day 5, the localization was similar to that
of day 1. At all time points, a proportion of cells appeared to contain either
cytoplasmic or nuclear p21, whereas a subpopulation appeared to contain
both forms. There is no clear correlation between the subcellular loca-
lization of p21 at each time point and the other parameters examined
in wild-type cells, including proliferation, apoptosis, and subcellular
localization of p27, PCNA, and p53.
Comparison of Cytoplasmic and Nuclear p21 Proteins in AECs
In order to further examine the role of p21 in cellular processes and to
determine the relevance of the alternative subcellular localisations of p21
in AECs, the cytoplasmic and nuclear forms of p21 in cultured AECs were
compared by Western blotting. Cytoplasmic and nuclear protein extracts
were prepared from AECs after 3 days in culture. The extracts were
separated by sodium dodecyl sulfate–polyacrylamide gel electrophoresis
(SDS-PAGE) and blots were probed using an antibody raised against full-
length p21. A 20-kDa protein corresponding to full-length p21 [23] was
detected in the nuclear extracts whereas a 17-kDa protein was detected in
cytoplasmic extracts (Figure 7A). Total protein extracts from AECs after 3
days in culture were then immunoprecipitated with an antibody raised
against the C-terminus of p21. Only the 20-kDa band was detected with this
antibody, indicating that the 17-kDa band represents a cleaved form of p21
that is truncated at its C-terminal end (Figure 7B).
FIGURE 7 (A) Cytoplasmic and nuclear protein extracts from AECs at day 3 of culture were blotted
against an antibody raised against full-length p21 (F-p21). Cytoplasmic p21 was a 17-kDa protein whereas
nuclear p21 was a 20-kDa protein. (B) Total protein extracts from AECs at day 3 of culture were probed
with either F-p21 or an antibody raised against the C-terminal of p21 (C-p21). The 20-kDa and 17-kDa
forms of p21 were detected with F-p21. Only the 20-kDa protein was observed with C-p21. Molecular
weights were determined by comparison with molecular weight standards run simultaneously.
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Complexes of Cytoplasmic and Nuclear p21Waf1/Cip1
In order to examine the activities of the full-length and truncated forms
of p21 proteins present in AECs, immunoprecipitations were carried out to
identify what cell cycle regulatory proteins, if any, were bound to each form
of p21. Total cell extracts from AECs after 3 days in culture were immuno-
precipitated with antibodies directed against PCNA, Cdk2, Cdk4, Cdk6,
cyclin D3, and cyclin E. The immunoprecipitated proteins were run on
SDS-PAGE gels, blotted, and probed using the antibody raised against the
full-length p21 protein. AECs cultured from p21-null mice were used as a
negative control. Full-length p21 was found to form complexes with PCNA,
Cdk2, Cdk4, Cdk6, cyclin D3, and cyclin E in AECs whereas the truncated
form of p21 interacted only with Cdk4 and cyclin D3 (Figure 8).
DISCUSSION
Although p21 plays a central role in regulation of cell proliferation, dif-
ferentiation, and apoptosis, the mechanisms by which p21 regulates these
processes are unclear. The activities of p21 appear to vary depending on a
number of factors, including cell type, subcellular localization, level of
expression, and post-translational modifications. In this study, p21-null mice
were used to examine the role of p21 in AECs. Despite its key role in cell fate
decisions, the only reported consequence of p21 deletion in vivo, in other-
wise normal healthy animals, is an increase in the rate of spontaneous malig-
nancies in older animals [28]. This suggests that p21 activities are largely
redundant. However, p21-specific effects become apparent when p21-defi-
cient animals and cells are subjected to various kinds of stress. In a mouse
model of chronic renal failure induced by partial renal ablation, p21-null
animals exhibit a more hyperplastic reaction that their wild-type counter-
parts, with up-regulation of PCNA in renal cells, resulting in the failure to
progress to end-stage renal disease [31]. Similarly, when cells are isolated
FIGURE 8 Total protein extracts from AECs at day 3 of culture were immunoprecipitated using number
of antibodies directed against cell cycle–related proteins, blotted, and then probed using
F-p21. Full-length p21 was complexed with PCNA, Cdk2, Cdk4, Cdk6, cyclin D3, and cyclin E, whereas
truncated p21 was complexed with Cdk4 and cyclin D3.
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from p217/7 animals and cultured in vitro, effects of p21 loss on cell cycle
progression and apoptosis become apparent [27]. These p21 knockout stu-
dies confirm the suggestion that p21 exerts a protective function against
stress [14].
The roles of p21 in lung cells were examined in this study. A slight altera-
tion in the morphology of airway epithelial cells in p217/7 mice towards a
more flattened appearance was the only observable effect of p21 loss in vivo.
p21 and p27 have been associated with differentiation of a number of cell
types, including keratinocytes [32] and muscle cells [33]. It is possible that
p21 plays a minor role in regulation of differentiation of healthy lung
epithelial cells or else that p27 and p57, or other proteins, are capable of
substituting to a large degree for more significant p21-related differentiation
effects. Although up-regulation of p27 and p57 was not observed in lung tis-
sue in the absence of p21, changes in their activities at the subcellular level
may occur to achieve these effects. Alternatively, if the primary role of p21 is
during times of stress, effects of its loss, such as up-regulation of p27 and
p57, may only be apparent in injured lungs and may not be evident in unin-
jured lungs as examined here. In support of this, levels of p27 were raised in
p217/7 cultured AECs indicating firstly, that a major role for p21 in AECs is
to respond to stress and secondly, that p27 may indeed substitute for the loss
of p21 under stressful circumstances. Animal model studies of lung injury
and disease using p21-null mice would allow further dissection of the activ-
ities of the Cip/Kip proteins in vivo.
A closer examination of the effects of p21 loss was possible using cul-
tured AECs isolated from p217/7 mice. In culture, p217/7 cells exhibit
increased rates of proliferation and apoptosis, demonstrating that p21 regu-
lates the rate of proliferation of AECs and also protects against apoptosis.
Sustained high levels of PCNA in p217/7 cultured cells indicate that regula-
tion of cell cycle regulatory proteins is altered in the absence of p21. The
greatest difference in PCNA expression levels was seen at day 5 of culture,
suggesting that other cell cycle regulatory proteins are also involved in the
induction of the high proliferation rates observed at the earlier time points.
Increased levels of p53 expression are also likely to be involved in the
increased rates of apoptosis in p217/7 cells. The effects of p21 loss on pro-
liferation and apoptosis demonstrate that p27 and p57 cannot fully compen-
sate for p21 in these cells, despite the increase in p27 protein expression.
No correlation was found between the subcellular localization of p21 in
wild-type cells and proliferation, apoptosis, and expression and subcellular
localization of p27, PCNA, and p53. The signaling pathways involved in these
processes are complex and are influenced by a wide range of factors. Addi-
tional experiments will be required to dissect the roles of individual proteins
such as p21. In order to more closely examine the functions of p21 in AECs,
the binding activities of cytoplasmic and nuclear p21 were determined and
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two distinct forms of p21 were identified. We are not aware of other reports
describing truncated mouse p21. Multiple forms of p21 have been reported
in human cells [34–42]. Alternative splice variants and post-translational
modifications such as hypophosphorylation and proteolytic cleavage pro-
duce forms of p21 with varying sizes and biological activities, although most
studies have been carried out using cell lines rather than normal cells. In
agreement with several of the human studies, the 17-kDa form of p21 pre-
sent in normal AECs is truncated at the C-terminal end and is localized to
the cytoplasm. As expected, we found that full-length mouse p21 forms com-
plexes with PCNA, Cdk2, Cdk4, Cdk6, cyclin D3, and cyclin E in AECs. In
contrast, truncated mouse p21 only binds cyclin D3 and Cdk4. Such com-
plexes have not previously been described in either mouse or human cells.
Poon and Hunter showed that a 19-kDa C-terminal truncated form of p21
could be induced in normal fibroblasts following exposure to high-dose
ultraviolet (UV) irradiation [39]. The truncated protein also accounted
for the majority of p21 protein in several untreated human carcinoma cell
lines. The 19-kDa p21 was detected in both nuclear and cytoplasmic frac-
tions, but a higher proportion was present in the cytoplasmic fraction and
unlike full-length p21, was not complexed to Cdk2 or PCNA. Caspase-
mediated proteolysis has been directly implicated in the production of
p21 fragments of varying sizes. A 16-kDa fragment of p21 was detected in
a tumor necrosis factor (TNF)-sensitive human cervical carcinoma cell line
during apoptosis induced by TNF treatment but localization and activity of
the fragment were not reported [40]. p53-dependent production of a 14-
kDa p21 fragment occurred in human myeoblastic leukemic cells but not
in normal human lung fibroblasts in response to g-irradiation [35]. The
14-kDa fragment was associated with cyclin A and Cdk2, but did not complex
with PCNA. Two reports describe truncated p21 in the A549 human lung
carcinoma cell line. The 20-kDa C-terminal truncated form of p21 observed
by Tchou and coworkers appeared during phorbol ester–induced G2/M
arrest but its subcellular localization was not reported [38]. Cytoplasmic
localization of a caspase-cleaved 15-kDa p21 fragment was also reported
[36]. This cleaved form of p21 failed to arrest cells in G1 phase and failed
to bind to PCNA but did bind Cdk2. We are currently investigating if the
17-kDa form of p21 described here in AECs occurs as a result of caspase clea-
vage and how its appearance correlates with phase of the cell cycle.
This is also the first report of truncated p21 interacting with either cyclin
D3 or Cdk4. The demonstration that cyclin D3/Cdk4 complexes can form
and become active in the absence of both p21 and p27 suggests that the pri-
mary role of p21 in cyclin/Cdk function is as regulator of subcellular loca-
lization and activity rather than facilitator of assembly [43]. Our results
support this hypothesis. Cleavage of the nuclear localization signal which
is also located at the C terminal end of p21 would prevent translocation
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of cyclin D3/Cdk4 complexes to the nucleus and their subsequent initiation
of cell cycle progression. This may be an important point of cell cycle regu-
lation in epithelial cells that are exposed to conflicting environmental sig-
nals such as mitogenic stimuli and lack of substrate attachment. The D-
type cyclins (D1, D2, and D3), which are up-regulated in response to mito-
genic signals, are rate-limiting controllers of G1 phase progression [44].
Individual D-type cyclins appear to be expressed within cells in varying pro-
portions in a lineage-specific manner but the functional significance of each
type is not clear. The role of CKI/cyclin D/Cdk4 and -Cdk6 complexes in
regulation of cell cycle progression is controversial. Once thought to be inac-
tive, it was later proposed that p21/cyclin D/Cdk complexes are in fact
active in the presence of low levels of p21 and are only inhibited when
p21 levels are high [45]. More recently, it has been suggested that cyclin
D/Cdk4 and cyclin D/Cdk6 complexes sequester CKIs in the nucleus, thus
permitting cyclin E/Cdk2 complexes to drive the cell cycle [1]. Only when
CKI levels become high enough will they bind to and inhibit cyclin E/cdk2
complexes and prevent cell cycle progression. The findings here suggest
that modifications of p21 in lung epithelial cells result in retention of p21
and some of its binding partners to the cytoplasm, thus modulating activity
of cell cycle regulatory proteins such as cyclin D3 and Cdk4. Dysregulation
of this mechanism in airway diseases such as asthma and cancer where there
is an increased localization of p21 to the nucleus may reflect the increased
proliferation of AECs in these conditions.
In summary, p21 regulates AEC proliferation and protects against apop-
tosis. Alternative forms of p21 in the cytoplasm and nuclei of AECs have
altered binding activities, which probably reflect differences in the functions
of p21 in these subcellular compartments.
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